Le Lézard
Classified in: Health, Business
Subjects: ERP, SCZ, DEI

Welltower Raises 2023 Guidance and Issues Business Update

TOLEDO, Ohio, Sept. 11, 2023 /PRNewswire/ -- Welltower® Inc. (NYSE: WELL) today announced that it has revised its 2023 outlook. The Company now expects to achieve normalized funds from operations attributable to common stockholders in a range of $3.51 - $3.60 per diluted share as compared to previous guidance of $3.48 - $3.59 per diluted share.  Additional details regarding the Company's updated guidance and other recent developments are contained in the following Business Update presentation:


About Welltower

Welltower® Inc. (NYSE: WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing, post-acute communities and outpatient medical properties. More information is available at www.welltower.com.


SOURCE Welltower Inc.

These press releases may also interest you

at 08:30
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is providing this update on the status...

at 08:20
Regal Components, Inc. has introduced custom core pins, sleeves, ejector pins, blades, and punches fabricated in special shapes and sizes from various materials for critical applications. Regal Special Mold & Die Components are suitable for a...

at 08:15
Thermo Fisher Scientific Inc. , the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic partnership to develop and commercially scale multiproduct platforms on an...

at 08:15
AuraVax Therapeutics, Inc., a biotechnology company developing novel immunotherapies to prevent and treat respiratory viruses, today announced that Thomas Finn and John Shiver have joined the company's board of directors. They will serve with...

at 08:15
PayGround, a healthcare fintech payments platform, today announced closing a $19.7M oversubscribed Series A financing led by SixThirty with participation from Rally Ventures, IA Capital Group, FCA Venture Partners and Plug and Play Ventures. The...

at 08:15
Ensysce Biosciences, Inc. ("Ensysce" or the "Company") , a clinical-stage company applying transformative chemistry to improve prescription drug safety, and OncoZenge AB ("OncoZenge") (STO:ONCOZ), a clinical-stage...

News published on and distributed by: